Professor Yu Wang obtained her Ph.D. in Biomedicine and Proteomics from the University of Auckland in 2003 and then worked as a Research Fellow at Maurice Wilkins Centre for Molecular Biodiscovery, in charge of the Proteomics Biodiscovery Center. She joined HKU as a Research Assistant Professor in 2004 and helped with the establishment of various proteomic facilities in the Genome Research Center, currently the Centre for PanorOmic Sciences. In 2008, Professor Yu Wang joined the Department of Pharmacology, currently the Department of Pharmacology and Pharmacy, HKU. She was promoted to the Associate Professor and the Professor in 2012 and 2018, respectively. Her current research focuses on several “druggale” targets in aging-related cardiovascular, metabolic, and cancer diseases. Her group is performing molecular, cellular, and pharmacological studies in both animal and human subjects to explore different approaches of intervention, largely based on druggable biomolecules adiponectin, lipocalin-2 and SIRT1. Professor Yu Wang has published over 200 journal articles/book chapters/invited reviews/commentaries and is among the top 1% of highly cited scientists with an H-index of 70.